amm ascent

meeting agenda

Wednesday, November 13, 2024

The meeting is scheduled to begin after the mRNA Health conference has concluded.

1:00 – 5:00 pm ET

Registration Desk, 1:1 Partnering, and Sponsor Exhibits Open (The Square, Lobby Level)

4:30 – 6:00 pm ET

Happy Hour (The Square, Lobby Level)

Thursday, November 14, 2024

9:00 am – 5:00 pm

Registration Desk, 1:1 Partnering, and Sponsor Exhibits Open (The Square, Lobby Level)

3:30 – 3:45 pm

Welcome (Avenue 34, Lobby Level)

3:45 – 4:45 pm

State of the Industry (Avenue 34, Lobby Level)
Panel of speakers presenting the latest in scientific developments, where the field is going next, and major issues on the horizon crossing standards, regulatory, and business.

4:45 – 5:15 pm

Break (Avenue 34, Lobby Level)

5:15 – 6:30 pm

Regulatory Outlook (Avenue 34, Lobby Level)
High level FDA officials provide the Agency’s perspective on the regulatory outlook for mRNA medicines, key issues they are grappling with, and the latest on platform technology guidance.

6:30 – 8:30 pm

Networking Reception (Terrace Room, Lower Lobby)

Friday, November 15, 2024

7:30 – 8:30 Am

Breakfast Buffet (Avenue 34, Lobby Level)

8:30 am – 1:00 pm

Registration Desk, 1:1 Partnering, and Sponsor Exhibits Open (The Square, Lobby Level)

8:30 – 8:45 Am

Day 2 Welcome (Avenue 34, Lobby Level)

8:45 – 9:45 Am

Scientific Update (Avenue 34, Lobby Level)
Panel discussion on hot topics in mRNA such as gene editing and protein replacement.

9:45 – 10:30 Am

Manufacturing, CMC, and Analytics (Avenue 34, Lobby Level)
Panel discussion considering how the mRNA sector is overcoming manufacturing bottlenecks experienced by the cell and gene therapy industry.

10:30 – 11:00 Am

Break (Avenue 34, Lobby Level)

11:00 AM – 12:00 PM

mRNA Delivery (Avenue 34, Lobby Level)
Panel discussion on the pressing issues in mRNA delivery, including novel delivery technologies and optimizing mRNA delivery for different applications.

12:00 – 12:45 Pm

Lunch Buffet (Avenue 34, Lobby Level)

12:45 – 1:05 Pm

2024 Election: What Does It Mean for the mRNA Sector? (Avenue 34, Lobby Level)
Presentation and outlook discussion about what the election outcomes mean for mRNA medicines.

1:05 – 1:45 Pm

Investor Perspectives (Avenue 34, Lobby Level)
Presentation of data about the industry and panel discussion with leading institutional investors sharing their perspective on what is driving their interest in mRNA technologies.

1:45 – 2:30 Pm

Closing Panel: Our mRNA Future (Avenue 34, Lobby Level)
Final panel shares thoughts about the future of mRNA development and what we expect over the next decade.